FibroGen (NASDAQ:FGEN) Now Covered by StockNews.com
StockNews.com initiated coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a report published on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a “buy” rating and set a $10.00 target price on shares of FibroGen in a report on Tuesday, March 18th. Read Our Latest […]
StockNews.com initiated coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a report published on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a “buy” rating and set a $10.00 target price on shares of FibroGen in a report on Tuesday, March 18th. Read Our Latest […]
